RRematiq provides AI-driven automation to simplify and speed up regulatory documentation in the life sciences sector. Its tools automate compliance tasks for medical device manufacturers and other life sciences stakeholders, generating and managing regulatory documents, templates, and workflows so teams can focus on innovation. The product works by integrating AI into clients’ regulatory processes to automatically draft, review, and track required documents, speeding up submissions and reducing manual work. Unlike more general compliance vendors, Rematiq combines deep medtech regulatory expertise with AI to specifically address the complex requirements of life sciences, aiming to cut the regulatory burden and R&D cycle time while helping clients bring products to market faster. The company’s goal is to enable faster, compliant innovation by turning regulatory chores into automated, auditable processes.
Work here?Claim your company
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
11-50
Company Stage
Seed
Total Funding
$5.9M
Headquarters
Berlin, Germany
Founded
2023
See people who can refer or advise you
Total Funding
$5.9M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Rematiq, a Berlin-based AI platform for medtech compliance automation, has raised €5 million in Seed funding. The round was led by Project A.
The news highlights recent financial activities: Rulemapping Group secured €12 million, Rematiq raised €5.4 million, and Skoove acquired Trala.
REMATIQ raised €5.4M to simplify MedTech compliance with AI. The funds will fuel growth across Europe and the U.S.
The start-up Rematiq has developed a tool that uses artificial intelligence to simplify the approval process for medical devices, specifically considering 15,000 guidelines for pacemakers. Recently, Rematiq secured a multi-million euro investment from investors.
Berlin-based startup REMATIQ has secured €5.4 million in seed funding led by Project A Ventures, with participation from Amino Collective, HelloWorld, and business angels. The company is developing an AI platform to automate compliance processes in medical technology, aiming to reduce documentation efforts by up to 90%. The funds will be used for technological development, team expansion, and international growth, particularly in Europe and the USA.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
11-50
Company Stage
Seed
Total Funding
$5.9M
Headquarters
Berlin, Germany
Founded
2023
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs